Category: drug costs

KFF Health News’ ‘What the Health?’: Hello, Trump. Bye-Bye, Biden.

With just days to go before the official launch of a new administration, the GOP-led Congress is putting together plans on how to enact incoming President Donald Trump’s agenda, with a particular emphasis on cutting spending on the Medicaid program. Meanwhile, the Biden administration makes major moves in its last days, including banning a controversial food dye and ordering cigarette companies to minimize their nicotine content. Joanne Kenen of Johns Hopkins University and Politico Magazine, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the latest KFF Health News “Bill of the Month” feature, about a colonoscopy that came with a much larger price tag than estimated.

Health Care Is Newsom’s Biggest Unfinished Project. Trump Complicates That Task.

As Gov. Gavin Newsom enters the second half of his final term, health care stands out as his most ambitious but glaringly incomplete initiative for California residents. The issue will likely shape his national profile for better or worse. And now, Donald Trump brings a new wrinkle.

How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.

Readers Embrace ‘Going It Alone’ Series on Aging and Chastise Makers of Pulse Oximeters

KFF Health News gives readers a chance to comment on a recent batch of stories.

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.

Listen: A Tussle With a Rattlesnake Can Take a Bite Out of Your Wallet

Listen to KFF Health News’ Jackie Fortiér recount how a backyard snakebite led to a harrowing hospitalization — and big bills — for a San Diego family.

What’s at Stake: A Pivotal Election for Six Big Health Issues

In the final days of the campaign, stark disagreements between Vice President Kamala Harris and former President Donald Trump over the future of American health care are on display — in particular, in sober warnings about abortion access, the specter of future cuts to the Affordable Care Act, and bold pronouncements about empowering activists eager […]

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.

KFF Health News’ ‘What the Health?’: Yet Another Promise for Long-Term Care Coverage

As part of her presidential campaign, Vice President Kamala Harris has rolled out a plan for Medicare to provide in-home long-term care services. The proposal would fill a longtime need for families trying to simultaneously care for young children and older parents, but its enormous price tag makes it a promise unlikely to be fulfilled. Meanwhile, a growing number of Republican candidates up and down the ballot facing voter backlash over their support for abortion restrictions are trying to reinvent their positions. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, excerpts from a KFF lunch with “Shark Tank” panelist and generic drug discounter Mark Cuban, who has been consulting with the Harris campaign about health care issues.

Employers Haven’t a Clue How Their Drug Benefits Are Managed

The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and insurers who hire them. But most employers seem to doubt that.